首页> 美国卫生研究院文献>World Journal of Clinical Oncology >Yttrium-90 microsphere selective internal radiation therapy for liver metastases following systemic chemotherapy and surgical resection for metastatic adrenocortical carcinoma
【2h】

Yttrium-90 microsphere selective internal radiation therapy for liver metastases following systemic chemotherapy and surgical resection for metastatic adrenocortical carcinoma

机译:Yttrium-90微球选择性内部放射治疗全身性化疗和手术切除后转移性肾上腺皮质癌的肝转移

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Adrenocortical carcinoma (ACC) is a rare malignancy with generally poor outcomes and limited treatment options. While surgical resection can be curative for early local disease, most patients present with advanced ACC owing to nonspecific symptoms. For those patients, treatment options include systemic chemotherapy and locoregional therapies including radiofrequency ablation and transarterial chemoembolization. We present the first reported case of utilizing yttrium-90 microsphere selective internal radiation therapy (SIRT) in combination with first line EDP-M (Etoposide, Doxorubicin, Cisplatin, Mitotane) chemotherapy and debulking surgical primary tumor resection for treatment of metastatic ACC. Stable complete radiologic response has been maintained after twelve months with resolution of clinical symptoms. These findings prompt the need for further consideration and studies to elucidate the role of SIRT in combination with systemic and surgical treatment for metastatic ACC.
机译:肾上腺皮质癌(ACC)是一种罕见的恶性肿瘤,其预后普遍较差,治疗选择有限。虽然手术切除可以治愈早期局部疾病,但大多数患者由于非特异性症状而出现晚期ACC。对于那些患者,治疗选择包括全身化疗和局部治疗,包括射频消融和经动脉化学栓塞。我们介绍了第一例报告的病例,该病例利用钇90微球选择性内部放射疗法(SIRT)结合一线EDP-M(依托泊苷,阿霉素,顺铂,米托坦)化疗和大剂量手术原发性肿瘤切除术治疗转移性ACC。经过十二个月的临床症状缓解,已维持了稳定的完全放射学反应。这些发现提示需要进一步考虑和研究,以阐明SIRT与全身和手术治疗联合治疗转移性ACC的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号